Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits

Παρόμοια τεκμήρια

• Risk factors determining the need for second-look endoscopy for peptic ulcer bleeding after endoscopic hemostasis and proton pump inhibitor infusion
  ανά: Cheng, Hsiu-Chi, κ.ά.
  Έκδοση: (2016)
• Role of proton pump inhibitors in the management of peptic ulcer bleeding
  ανά: Lin, Hwai-Jeng
  Έκδοση: (2010)
• Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection
  ανά: Tsai, Jai-Jen, κ.ά.
  Έκδοση: (2009)
• High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
  ανά: Hsieh, Yu-Hsi, κ.ά.
  Έκδοση: (2013)
• Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy
  ανά: Yen, Hsu-Heng, κ.ά.
  Έκδοση: (2012)